Related Experiment Video

Updated: Jul 16, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Transforming growth factor-beta/connective tissue growth factor axis in the kidney

Weier Qi1, Xinming Chen, Philip Poronnik

  • 1Department of Medicine, University of Sydney, Level 3, Wallace Freeborn Professorial Block, Royal North Shore Hospital, St. Leonards, NSW 2065, Australia.

The International Journal of Biochemistry & Cell Biology
|February 16, 2007
PubMed

Insights

Transforming growth factor-beta(1) (TGFbeta(1)) drives kidney fibrosis in diabetic nephropathy. Targeting connective tissue growth factor (CTGF), a downstream mediator, offers a promising therapeutic strategy for kidney fibrosis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathophysiology

Background:

  • Transforming growth factor-beta(1) (TGFbeta(1)) is a key fibrogenic and inflammatory cytokine implicated in kidney pathophysiology.
  • Dysregulation of TGFbeta(1) is associated with the development and progression of diabetic nephropathy.
  • Connective tissue growth factor (CTGF) acts as a downstream mediator of TGFbeta(1) in kidney fibrosis.

Purpose of the Study:

  • To investigate the specific role of CTGF in kidney fibrosis.
  • To evaluate CTGF as a potential therapeutic target for diabetic nephropathy.
  • To explore strategies for targeting CTGF, given the challenges of direct TGFbeta(1) inhibition.

Main Methods:

  • The study focuses on the molecular mechanisms and signaling pathways involving TGFbeta(1) and CTGF in kidney proximal tubule cells.
  • Analysis of CTGF's role as a downstream mediator of TGFbeta(1) in fibrogenic pathways.
  • Evaluation of CTGF as a specific target for therapeutic intervention in renal fibrosis.

Main Results:

  • CTGF plays a specific and critical role in the fibrogenic pathways within kidney proximal tubule cells.
  • CTGF facilitates TGFbeta(1) signaling, thereby promoting renal fibrosis.
  • CTGF emerges as a more specific and potentially more tractable target than TGFbeta(1) itself.

Conclusions:

  • CTGF is a crucial mediator in TGFbeta(1)-induced kidney fibrosis.
  • Targeting CTGF presents a promising therapeutic avenue for managing diabetic nephropathy and kidney fibrosis.
  • Developing strategies to inhibit CTGF may overcome the limitations associated with directly targeting TGFbeta(1).

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...